Ronald van der Sluis
Wetenschappelijk adviseur Instantie voor Dierwelzijn / gast
- Naam
- Dr. R.J. van der Sluis
- Telefoon
- +31 71 527 2727
- r.j.van.der.sluis@science.leidenuniv.nl
- ORCID iD
- 0000-0002-3435-8356
Wetenschappelijk adviseur Instantie voor Dierwelzijn / gast
- Wiskunde en Natuurwetenschappen
- Bedrijfsvoering
- Faculteitsbureau
- Korporaal S.J.A., Sluis R.J. van der, Eck M. van & Hoekstra M. (2021), Bone marrow Ts65Dn trisomy-induced changes in platelet functionality and lymphocytopenia do not impact atherosclerosis susceptibility in mice, Journal of Cardiovascular Development and Disease 8(9): 110.
- Hoekstra M., Ouweneel A.B., Price J., Geest R. van der, Sluis R.J. van der, Geerling J.J., Nahon J.E. & Eck M. van (2020), SR-BI deficiency disassociates obesity from hepatic steatosis and glucose intolerance development in high fat diet-fed mice, Journal of Nutritional Biochemistry 89: 108564.
- Sluis R.J. van der (19 november 2020), Cholesterol metabolism in mouse models of atherosclerosis and adrenal steroidogenesis (Dissertatie. Leiden Academic of Drug Research (LACDR), Faculty of Science , Leiden University). Promotor(en) en copromotor(en): Eck M. van, Hoekstra M.
- Sluis R.J. van der, Depuydt M.A.C., Eck M. van & Hoekstra M. (2020), VLDL/LDL serves as the primary source of cholesterol in the adrenal glucocorticoid response to food deprivation, Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids 1865(7): 158682.
- Sluis R.J. van der & Hoekstra M. (2020), Glucocorticoids are active players and therapeutic targets in atherosclerotic cardiovascular disease, Molecular and Cellular Endocrinology 504: 110728.
- Hoekstra M., Sluis R.J. van der, Hildebrand R.B., Lammers B., Zhao Y., Praticò D., Berkel T.J.C. van, Rensen P.C.N., Kooijman S., Jauhiainen M. & Eck M. van (2020), Disruption of PLTP (phospholipid transfer protein)-mediated HDL (high-density lipoprotein) maturation reduces SR-BI (scavenger receptor BI) deficiency-driven atherosclerosis susceptibility despite unexpected metabolic complications, Arteriosclerosis, Thrombosis, and Vascular Biology 40(3): 611-623.
- Sluis R.J. van der, Depuydt M.A.C., Verwilligen R.A.F., Hoekstra M. & Eck M. van (2019), Elimination of adrenocortical apolipoprotein E production does not impact glucocorticoid output in wild-type mice, Molecular and Cellular Endocrinology 490: 21-27.
- Geest R. van der, Sluis R.J. van der, Groen A.K., Eck M. van & Hoekstra M. (2019), Cholestasis-associated glucocorticoid overexposure does not increase atherogenesis, Journal of Endocrinology 242(2): 1-12.
- Hoekstra M., Ouweneel A.B., Nahon J.E., Geest R. van der, Kröner M.J., Sluis R.J. van der & Eck M. van (2019), ATP-binding cassette transporter G1 deficiency is associated with mild glucocorticoid insufficiency in mice, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1864(4): 443-451.
- Sluis R.J. van der, Verwilligen R.A.F., Lendvai Z., Wever R., Hoekstra M. & Eck M. van (2018), HDL is essential for atherosclerotic lesion regression in Apoe knockout mice by bone marrow Apoe reconstitution, Atherosclerosis 278: 240-249.
- Snip O.S.C., Hoekstra M., Zhao Y., Calpe-Berdiel L., Vulve J., Carles Escola-Gil J., Foks A., Sluis R.J. van der, Blanco-Vaca F., Berkel T.J.C. van, Kuivenhoven J. & Eck M. van (2018), Reduced systemic inflammation and increased reverse cholesterol transport together drive leukocyte ABCA1-mediated protection against atherosclerosis, Atherosclerosis 275: e43-e44.
- Berg R. van den, Kooijman S., Noordam R., Ramkisoensing A., Abreu-Vieira G., Tambyrajah L.L., Dijk W., Ruppert P., Mol I.M., Kramar B., Caputo R., Puig L.S., Ruiter E.M. de, Kroon J., Hoekstra M., Sluis R.J. van der, Meijer O.C., Dijk Willems K. van, Kerkhof L.W.M. van, Christodoulides C., Karpe F., Gerhart-Hines Z., Kersten S., Meijer J.H., Coomans C.P., Heemst D. van, Biermasz N.R. & Rensen P.C.N. (2018), A Diurnal Rhythm in Brown Adipose Tissue Causes Rapid Clearance and Combustion of Plasma Lipids at Wakening, Cell Reports 22(13): 3521-3533.
- Ouweneel A.B., Sluis R.J. van der, Nahon J.E., Eck M. van & Hoekstra M. (2017), Simvastatin treatment aggravates the glucocorticoid insufficiency associated with hypocholesterolemia in mice, Atherosclerosis 261: 99-104.
- Geest R. van der, Ouweneel A.B., Sluis R.J. van der, Groen A.K., Eck M. van & Hoekstra M. (2016), Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice, Toxicology and Applied Pharmacology 306: 1-7.
- Stoep M. van der, Li Z., Sluis R.J. van der, Berkel T.J.C. van, Eck M. van, Hoekstra M. & Korporaal S.J.A. (2013), Liver X receptor (LXR) activation influences murine platelet count only under normolipidemic conditions, Journal of Thrombosis and Haemostasis 11: 910-910.
- Stoep M. van der, Li Z., Calpe-Berdiel L., Sluis R.J. van der, McKinnon H.J., Smit M.J., Berkel T.J.C. van, Van Eck M., Hoekstra M. & Korporaal S.J.A. (2013), Liver X receptor (LXR) agonist T0901317 induces regression of early and advanced atherosclerotic lesions under normolipidemic conditions in mice: PB 1.32-1, Journal of Thrombosis and Haemostasis 11(s2): 520-520.
- Hoekstra M., Sluis R.J. van der, Eck M. van & Berkel T.J.C. van (2013), Adrenal-Specific Scavenger Receptor BI Deficiency Induces Glucocorticoid Insufficiency and Lowers Plasma Very-Low-Density and Low-Density Lipprotein Levels in Mice, Arteriosclerosis, Thrombosis, and Vascular Biology 33(2): e39-46.
- Li Z., Wang Y., Sluis R.J. van der, Hoorn J.W.A. van der, Princen H.M.G., Eck M. van, Berkel T.J.C. van, Rensen P.C.N. & Hoekstra M. (2012), Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice, Biochemical Pharmacology 84(6): 821-829.
- Sluis Ronald J. van der, Puijvelde G.H. van, Berkel T.J.C. van & Hoekstra M. (2012), Adrenalectomy stimulates the formation of initial atherosclerotic lesions: Reversal by adrenal transplantation, Atherosclerosis 221(1): 76-83.
Geen relevante nevenwerkzaamheden